South Korea's Ministry of Food and Drug Safety (MFDS) approved an AI-based cardiac arrest prediction software as an innovative medical device. The software was developed by a South Korea based medical AI solutions development company, VUNO. Clinical testing is ongoing for the software based on a clinical trial plan approved by the MFDS in June. The company was also selected to be part of a project, which is launched by the National IT Industry Promotion Agency (NIPA) under the Ministry of Science and ICT (MSIT) to demonstrate an AI-powered system for medical image based analysis and diagnosis.
Register Email now for Weekly Promotion Stock
100% free, Unsubscribe any time!Add 1: Room 605 6/F FA YUEN Commercial Building, 75-77 FA YUEN Street, Mongkok KL, HongKong Add 2: Room 405, Building E, MeiDu Building, Gong Shu District, Hangzhou City, Zhejiang Province, China
Whatsapp/Tel: +8618057156223 Tel: 0086 571 86729517 Tel in HK: 00852 66181601
Email: [email protected]